(Q64065293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

title

Immunosuppressive therapy with rituximab in common variable immunodeficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

0 references

0 references

0 references

common variable immunodeficiency

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

author name string

Antonio Pecoraro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Ludovica Crescenzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Maria Rosaria Galdiero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Giancarlo Marone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Felice Rivellese

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Francesca Wanda Rossi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Amato de Paulis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Arturo Genovese

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

language of work or name

English

0 references

publication date

6 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Molecular Allergy

26 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

issue

1

0 references

page(s)

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

26 April 2020

copyright license

start time

6 May 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis.

1 reference

12 December 2020

Rituximab: an insider's historical perspective.

1 reference

12 December 2020

Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency

1 reference

12 December 2020

Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature

1 reference

12 December 2020

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab

1 reference

12 December 2020

Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency

1 reference

12 December 2020

Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency

1 reference

12 December 2020

Common variable immune deficiency and autoimmunity

1 reference

12 December 2020

Structural basis for recognition of CD20 by therapeutic antibody Rituximab

1 reference

12 December 2020

Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia

1 reference

12 December 2020

Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab

1 reference

12 December 2020

Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency

1 reference

12 December 2020

Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency

1 reference

12 December 2020

Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID)

1 reference

12 December 2020

The EUROclass trial: defining subgroups in common variable immunodeficiency.

1 reference

12 December 2020

NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.

1 reference

12 December 2020

Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration

1 reference

12 December 2020

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

1 reference

12 December 2020

Autoimmune manifestations in common variable immunodeficiency

1 reference

12 December 2020

Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.

1 reference

12 December 2020

Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients

1 reference

12 December 2020

Renal granuloma and immunoglobulin M-complex glomerulonephritis: a case of common variable immunodeficiency?

1 reference

12 December 2020

The quality of life of children and adolescents with X-linked agammaglobulinemia.

1 reference

12 December 2020

Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency.

1 reference

12 December 2020

Granulomatous disease in common variable immunodeficiency

1 reference

12 December 2020

Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model

1 reference

12 December 2020

Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).

1 reference

12 December 2020

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

1 reference

12 December 2020

Rituximab: mechanism of action

1 reference

12 December 2020

Thymoma-Associated Immunodeficiency: A Syndrome Characterized by Severe Alterations in NK, T and B-Cells and Progressive Increase in Naïve CD8+ T Cells

1 reference

12 December 2020

Effectiveness of Immunoglobulin Replacement Therapy on Clinical Outcome in Patients with Primary Antibody Deficiencies: Results from a Multicenter Prospective Cohort Study

1 reference

12 December 2020

1 reference

12 December 2020

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia

1 reference

12 December 2020

The cell biology of phagocytosis

1 reference

12 December 2020

Proteomic analysis of sera from common variable immunodeficiency patients undergoing replacement intravenous immunoglobulin therapy

1 reference

12 December 2020

Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients

1 reference

12 December 2020

Morbidity and mortality in common variable immune deficiency over 4 decades

1 reference

12 December 2020

Follicular lymphoma and the immune system: from pathogenesis to antibody therapy

1 reference

12 December 2020

Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27.

1 reference

12 December 2020

Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts

1 reference

12 December 2020

Autoimmune cytopenias in common variable immunodeficiency

1 reference

12 December 2020

Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels

1 reference

12 December 2020

Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).

1 reference

12 December 2020

Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency

1 reference

12 December 2020

Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients

1 reference

12 December 2020

Concurrent Takayasu arteritis with common variable immunodeficiency and moyamoya disease

1 reference

12 December 2020

Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients

1 reference

12 December 2020

B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies

1 reference

12 December 2020

Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell-mediated antibody-dependent cellular cytotoxicity

1 reference

12 December 2020

Humoral pattern recognition and the complement system.

1 reference

12 December 2020

Common variable immunodeficiency-associated granulomatous and interstitial lung disease

1 reference

12 December 2020

The variable in common variable immunodeficiency: a disease of complex phenotypes

1 reference

12 December 2020

Clinical picture and treatment of 2212 patients with common variable immunodeficiency

1 reference

12 December 2020

Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.

1 reference

12 December 2020

Calculated globulin (CG) as a screening test for antibody deficiency

1 reference

12 December 2020

Rituximab and immune deficiency: case series and review of the literature.

1 reference

12 December 2020

Altered serum cytokine signature in common variable immunodeficiency

1 reference

12 December 2020

Immunoglobulin replacement therapy in secondary hypogammaglobulinemia

1 reference

12 December 2020

Serum IL-12 and soluble IL-2 receptor levels as possible biomarkers of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency: a case report.

1 reference

12 December 2020

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study

1 reference

12 December 2020

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

1 reference

12 December 2020

IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes.

1 reference

12 December 2020

A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas

1 reference

12 December 2020

Complement System Part I - Molecular Mechanisms of Activation and Regulation

1 reference

12 December 2020

Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency--histologic and immunohistochemical analyses of 16 cases

1 reference

12 December 2020

Efficacy of subcutaneous immunoglobulins in primary immunodeficiency with Crohn's-like phenotype: report of a case.

1 reference

12 December 2020

Successful Treatment of ANCA-Associated Vasculitis in the Setting of Common Variable Immunodeficiency Using Rituximab

1 reference

12 December 2020

Rituximab in refractory sarcoidosis: a single centre experience

1 reference

12 December 2020

Progression of Common Variable Immunodeficiency Interstitial Lung Disease Accompanies Distinct Pulmonary and Laboratory Findings

1 reference

12 December 2020

Nutritional Status in Agammaglobulinemia: An Italian Multicenter Study

1 reference

12 December 2020

Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia

1 reference

12 December 2020

The autoimmune conundrum in common variable immunodeficiency disorders

1 reference

12 December 2020

International Consensus Document (ICON): Common Variable Immunodeficiency Disorders

1 reference

12 December 2020

Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia.

1 reference

12 December 2020

Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease.

1 reference

12 December 2020

Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes

1 reference

12 December 2020

Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency

1 reference

12 December 2020

Bronchus-associated Lymphoid Tissue in Kabuki Syndrome with Associated Hyper-IgM Syndrome/Common Variable Immunodeficiency.

1 reference

12 December 2020

Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency

1 reference

12 December 2020

NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.

1 reference

12 December 2020

Clonal Lymphoproliferations in a Patient With Common Variable Immunodeficiency

1 reference

12 December 2020

Off-label use of rituximab for systemic lupus erythematosus in Europe

1 reference

12 December 2020

Dynamics of Epstein-Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy

1 reference

12 December 2020

Neurologic Complications of Common Variable Immunodeficiency

1 reference

12 December 2020

Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies

1 reference

12 December 2020

Immunodeficiency Presenting as an Undiagnosed Disease

1 reference

12 December 2020

FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).

1 reference

12 December 2020

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies.

1 reference

12 December 2020

Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia

1 reference

12 December 2020

Heart failure not responsive to standard immunosuppressive therapy is successfully treated with high dose intravenous immunoglobulin therapy in a patient with Eosinophilic Granulomatosis with Polyangiitis (EGPA).

1 reference

12 December 2020

Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency

1 reference

12 December 2020

Abnormality of regulatory T cells in common variable immunodeficiency.

1 reference

12 December 2020

Delay in diagnosis affects the clinical outcome in a cohort of cvid patients with marked reduction of iga serum levels

1 reference

12 December 2020

British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.

1 reference

12 December 2020

The TH1 phenotype of follicular helper T cells indicates an IFN-γ-associated immune dysregulation in patients with CD21low common variable immunodeficiency.

1 reference

12 December 2020

Granulomatous-Lymphocytic Interstitial Lung Disease in a Patient With Common Variable Immunodeficiency

1 reference

12 December 2020

Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency.

1 reference

12 December 2020

Total and High Molecular Weight Adiponectin Expression Is Decreased in Patients with Common Variable Immunodeficiency: Correlation with Ig Replacement Therapy.

1 reference

12 December 2020

Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach

1 reference

12 December 2020

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

1 reference

12 December 2020

Chronic Diarrhea in Common Variable Immunodeficiency: a Case Series and Review of the Literature.

1 reference

12 December 2020

Intra cranial granulomatous disease in common variable immunodeficiency: Case series and review of the literature

1 reference

12 December 2020

Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients with Associated Sjögren's Syndrome: Post-hoc Analyses from the EMBODY Trials.

1 reference

12 December 2020

B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.

1 reference

12 December 2020

Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.

1 reference

12 December 2020

Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses

1 reference

12 December 2020

Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS)

1 reference

12 December 2020

Validation of Calculated Globulin (CG) as a Screening Test for Antibody Deficiency in an Italian University Hospital

1 reference

12 December 2020

Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy

1 reference

12 December 2020

Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications

1 reference

12 December 2020

Gastroduodenal Disorders in Patients with CVID Undergoing Immuno-globulin Therapy

1 reference

12 December 2020

Efficacy of rituximab as a single-agent therapy for the treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency (CVID)

1 reference

12 December 2020

Psoriasis in a cohort of patients with common variable immunodeficiency

1 reference

12 December 2020

Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency

1 reference

12 December 2020

Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders

1 reference

12 December 2020

Evidence-based management of immune thrombocytopenia: ASH guideline update

1 reference

12 December 2020

Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group

1 reference

12 December 2020

1 reference

12 December 2020

Incidence, risk factors, and clinical significance of Epstein-Barr virus reactivation in myelodysplastic syndrome after allogeneic haematopoietic stem cell transplantation

1 reference

12 December 2020

British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non‐infectious complications of Common Variable Immunodeficiency Disorders

1 reference

12 December 2020

10.1186/S12948-019-0113-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31080365%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference